Previous Article | Next Article ![]()
Infection and Immunity, December 2008, p. 5624-5631, Vol. 76, No. 12
0019-9567/08/$08.00+0 doi:10.1128/IAI.00534-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Departments of Pediatric Dentistry and Microbiology, University of Alabama at Birmingham Schools of Medicine and Dentistry, Birmingham, Alabama 35244,1 Department of Microbiology and Molecular Genetics, College of Medicine and College of Life Science and Agriculture, Burlington, Vermont 054052
Received 30 April 2008/ Returned for modification 17 May 2008/ Accepted 29 September 2008
|
|
|---|
|
|
|---|
S. parasanguinis possesses long peritrichous fimbriae. Mature Fap1, a 200-kDa glycoprotein, is a major fimbrial subunit and is responsible for bacterial adhesion in an in vitro tooth model, saliva-coated hydroxyapatite (SHA) (29). Deficiency in an accessory Sec protein, SecA2, blocks Fap1 export and also inhibits secretion of FimA (7), a key virulence factor of S. parasanguinis-induced infective endocarditis (4). Fap1 homologs have been isolated as important adhesins in other gram-positive bacteria, including Streptococcus gordonii (2), Streptococcus sanguinis (20), Streptococcus pneumoniae (26), Streptococcus agalactiae (22), Staphylococcus aureus (23), and Staphylococcus epidermidis (31). Fap1-like proteins in S. gordonii and Staphylococcus aureus have been implicated in the pathogenesis of infective endocarditis (23, 25). Fap1, a glycosylated cell-wall-anchored adhesin, contains a long signal sequence at the amino terminus which directs Fap1 export in conjunction with its C-terminal classic cell wall sorting signal. Fap1 also possesses two extensive serine-rich repeat regions that appear to be modified by O-linked glycan moieties (28, 29). Biogenesis of Fap1 is mediated by a cluster of 11 genes (gly, nss, galT1 and -2, secY2, gap1 to -3, secA2, gtf1, and gtf2). The functions of many of these genes have been determined (27, 30). For instance, inactivation of the Gtfs renders the mutants unable to glycosylate Fap1 and leads to the production of an unglycosylated high-molecular-mass Fap1 precursor A (3, 27). SecY2 and Gap3 mutants fail to express mature Fap1 and instead produce an incompletely glycosylated and distinct high-molecular-mass Fap1 precursor B (19, 27).
In the process of identifying adhesins of S. parasanguinis that mediate bacterial interactions with salivary components, we had previously isolated a series of chemically mutagenized strains which do not attach to SHA and cannot form fimbriae (11, 13). These nonadherent mutants were isolated based on their inability to interact with SHA (13). Among these mutants, VT321 has been partially characterized and has already been linked to the Fap1 biogenesis defect (12), albeit the nature of mutation(s) has not been studied. However, it is unknown whether other nonadherent mutants also have defects in Fap1 and Fap1 biogenesis. Further characterization of these mutants will facilitate our understanding of Fap1 biogenesis and Fap1-dependent and -independent bacterial adhesion mechanisms.
In this report, we characterized these mutants using a forward genetic complementation strategy, determined that a new mutant group VT324 was defective in glycosylation-associated protein Gap1, and show for the first time that a conserved C-terminal 13-amino-acid motif of Gap1 is required for Gap1 function and is necessary for Fap1 maturation.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Strains and plasmids used in this study
|
|
View this table: [in a new window] |
TABLE 2. Primers used in this study
|
0.6) were harvested and lysed in 40 µl lysis buffer (1:10 dilution of LambdaSa2 lysin [GenBank no. AE014275] in phosphate-buffered saline buffer [0.1 M NaCl, 0.01 M NaH2PO4, pH 7.4]) for 10 min at room temperature before adding 5x sodium dodecyl sulfate (SDS) loading buffer (250 mM Tris-HCl [pH 6.8], 10% SDS, 0.5% bromophenol blue, 50% glycerol; 500 mM β-mercaptoethanol). The extracted cell lysates were subjected to electrophoresis on 4 to 12% precast gradient gels (Cambrex) and Western blotting analysis. Culture supernatants of nonadherent mutants were prepared as described previously (27). In brief, proteins precipitated from 0.5 ml of culture media of each nonadherent mutant were dissolved in 30 µl 1x SDS loading buffers. Fifteen microliters of each of the prepared samples was subjected to Western blotting analysis using Fap1-specific antibodies. Expression of Fap1 in wild-type strain FW213 and expression in the fap1 mutant were used as a positive and negative control, respectively. The defined secY2, gap1, gap3, secA2, gtf1, and gtf2 mutants were used as reference strains to determine relevant gene mutations in nonadherent mutants. Genetic complementation of nonadherent mutants analyzed by BactELISA and Western blotting. BactELISA and Western blotting analyses were performed to assay the genetic complementation of nonadherent mutants. The full-length DNA sequences coding for SecY2, Gap1, Gap3, Gtf1, and Gtf2 were amplified from the genomic DNA of S. parasanguinis FW213 using the gene-specific primers listed in Table 2. The amplified PCR products for SecY2, Gap1, Gap3, and Gtf2 were digested with the restriction enzymes SalI and KpnI and inserted into the same restriction sites of the E. coli-Streptococcus shuttle vector pVT1666 (8) to create corresponding recombinant plasmids. The Gtf1 PCR product was digested with the restriction enzyme BglII and cloned into the BamHI site of the E. coli-Streptococcus shuttle vector pVT1666 to yield pVPT-Gtf1. The resulting pVPT derivatives were transformed into related mutants. Plasmid pVA838::VT1175 (6, 28) with the full-length fap1 gene was transformed into the fap1-defective nonadherent mutants. The chosen nonadherent mutants and their complemented strains were analyzed by BactELISA as previously described (10). Fap1-specific antibody mAbF51 was used as a primary antibody to detect Fap1 expression. The assays were performed in triplicate in three independent experiments.
Western blot analyses were used to further confirm the genetic complementation of nonadherent mutants with three Fap1-specific antibodies, mAbE42, mAbD10, and mAbF51.
Adhesion of complemented strains to SHA. Adhesion of S. parasanguinis FW213 to SHA was performed as described previously (29). FW213, the fap1 mutant, nonadherent mutants, and their complemented strains were labeled with [3H]thymidine and grown to an optical density at 470 nm of 0.8. One milliliter of radiolabeled bacteria was incubated with pretreated SHA beads in scintillation vials at 37°C for 2 h. The unbound bacteria remaining in supernatants were transferred to new scintillation vials, the beads bound with bacteria were washed three times with 0.05 M phosphate buffer (pH 6.0), and the corresponding radioactivities were counted and used to calculate adhesion levels of the tested strains. Fifty microliters of radiolabeled bacteria was used to calculate the labeling efficiency of the chosen strains.
Sequence analysis. PCR products of the gtf1 gene were amplified from the genomic DNA of strains VT343 and VT508 using the primer pair Gtf1-BglII-F and Gtf1-BglII-R. The PCR product of the gap1 gene was amplified from the genomic DNA of VT324 using the primer pair Gap1-SalI-F and Gap1-KpnI-R. The PCR product corresponding to the N-terminal region of Fap1 was amplified from the genomic DNA of VT325 using the primer pair Fap1-N-F and Fapl-N-R. PCR products encoding the cell wall anchor (CWA) domain of Fap1 were amplified from the genomic DNA samples of VT321, VT361, VT377, VT379, and VT380 using the primer pair Fap1-C-F1/F2 and Fapl-C-R. The amplified PCR products were sequenced using same gene-specific primer pairs and analyzed with ClustalW, DNAstar, and NCBI tools.
Gap1 C-terminal site-directed mutagenesis. Plasmid pVPT-Gap1 (Table 1) containing the full-length gap1 gene was used as a template for Gap1 C-terminal site-directed mutagenesis to mutate a conserved amino acid, tryptophan (W), into a disfavored amino acid, alanine (A), and favored amino acid, tyrosine (Y). Site-directed mutagenesis was carried out by PCR utilizing a QuickChange XL mutagenesis kit (Stratagene, La Jolla, CA). Two primer pairs, Gap1 (W518A)-F and Gap1 (W518A)-R and Gap1 (W518Y)-F and Gap1 (W518Y)-R (Table 2), were used to construct site-directed mutations. The resulting plasmids, pVPT-Gap1(W518A) and pVPT-Gap1(W518Y) (Table 1), were confirmed by DNA sequencing and then transformed into a Gap1-null mutant, respectively, to detect the Fap1 expression profile. The expression of FimA in the wild-type strain, fap1 mutant, VT324, Gap1 W518A mutant, and Gap1 W518Y mutant was used as a loading control.
In vitro GST pull-down assays.
To examine the in vitro interaction between Gap1, Gap1(
513-525), and Gap3, the DNA sequences of the full-length Gap1 and the truncated Gap1 were amplified from the genomic DNA samples of S. parasanguinis FW213 and VT324, respectively, using primer pairs Gap1-EcoRI-F and Gap1-BamHI-R or Gap1(
513-525)-BamHI-R (Table 2). The amplified PCR products were then digested with the restriction enzymes EcoRI and BamHI and inserted into the same restriction sites of pGEX-5X-1 to produce fusion plasmids pGEX-5X-1::Gap1 and pGEX-5X-1::GST-Gap1(
513-525), respectively. The glutathione S-transferase (GST), GST-Gap1, and GST-Gap1(
513-525) fusion proteins were purified using glutathione Sepharose 4B beads (Amersham) according to the manufacturer's instructions. The purified proteins were subjected to SDS-polyacrylamide gel electrophoresis analysis by Coommassie brilliant blue staining. Plasmid pBD-Gap3 (Table 1) was used as a template to in vitro translate the c-Myc-tagged Gap3 using the TnT quick-coupled transcription/translation system (Promega) following the manufacturer's instructions. The expression of c-Myc-Gap3 protein was detected by Western blot analysis using anti-c-Myc antibody (1:500 dilution). For the in vitro GST pull-down assay, 5 µg of GST, GST-Gap1, or GST-Gap1(
513-525) fusion proteins in NETN binding buffer (20 mM Tris-HCl [pH 7.2], 50 mM NaCl, 1 mM EDTA, 0.2% NP-40) was mixed with 5 µl of in vitro-translated c-Myc-Gap3 separately in a final volume of 200 µl NETN binding buffer and incubated on a rotary shaker at 4°C overnight. The beads were washed three times with 600 µl NETN binding buffer, and the bound proteins were eluted by boiling in the SDS sample loading buffer and subjected to Western blotting analysis with anti-c-Myc antibody (1:500 dilution).
|
|
|---|
Phenotypes of gtf1 and fap1 nonadherent mutants. Since Fap1 is required for bacterial adhesion, we examined Fap1 expression profile of the isolated mutants by Western blotting analysis using three available Fap1-specific antibodies. mAbE42 is a peptide-specific antibody, whereas mAbD10 and mAbF51 are glycan-specific antibodies recognizing different epitopes. Only mature Fap1 reacts with mAbF51 (27). Wild-type bacteria expressed the mature 200-kDa Fap1 that reacts with all three monoclonal antibodies (Fig. 1A, lane 1). The first group of mutants, VT343 and VT508, expressed a 360-kDa polypeptide when probed with mAbE42 (Fig. 1A, top panel, lanes 3 and 4). This high-molecular-mass protein did not react with glycan-specific antibodies (Fig. 1A, middle and bottom panels, lanes 3 and 4), suggesting it is not glycosylated. This Fap1 expression profile is similar to that observed with the gtf1 or gtf2 mutant (Fig. 1A, lanes 5 and 6). Therefore, we transformed VT343 and VT508 with pVPT-Gtf1 and pVPT-Gtf2, respectively, to carry out genetic complementation experiments. Only pVPT-Gtf1 restored the production of mature Fap1 (Fig. 1B), suggesting both mutants are defective in the gtf1 gene. The complementation was further confirmed by Western blot analysis. Like the wild-type bacteria, the complemented strains all produced mature 200-kDa Fap1 (Fig. 1C, lanes 1, 4, and 6). These results demonstrate that VT343 and VT508 are gtf1 mutants.
![]() View larger version (26K): [in a new window] |
FIG. 1. Characterization of nonadherent gtf1 mutants. (A) Fap1 expression profile of the first group of mutants. The Fap1 expression profiles of cell lysates of the wild type (WT) (lane 1), fap1 mutant (lane 2), VT343 (lane 3), VT508 (lane 4), gtf1 mutant (lane 5), and gtf2 mutant (lane 6) were determined by Western blotting analysis with three Fap1-specific antibodies, mAbE42 (top panel), mAbD10 (middle panel), and mAbF51 (bottom panel). (B) Genetic complementation of VT343 and VT508 with genes coding for glycosyltransferases Gtf1 and Gtf2 and analyzed by BactELISA using mAbF51. (C) Western blotting analyses of the wild type (lane 1), fap1 mutant (lane 2), VT343 (lane 3), and VT508 (lane 5) and their complemented strains (lanes 4 and 6) using Fap1-specific antibodies. (D) Diagrammatic depiction of gtf1 alleles from VT343 and VT508. (E) Adhesion of S. parasanguinis FW213 and its derivatives. Wild type FW213, the fap1 mutant, VT343, and VT508 and their complemented strains were assayed for their ability to bind to SHA.
|
Since Fap1 is responsible for bacterial adhesion, we performed adhesion assays to characterize the complemented mutants. VT343 and VT508 can be partially complemented by the full-length gtf1 gene; the adherence levels of the complemented VT343 and VT508 reached 70% and 65% of the wild-type level (Fig. 1E). VT508 was selected by bacterial inability to agglutinate Fap1-specific mAbF51; therefore, it is not surprising to find that the mutant has a defect in Gtf1 as Gtf1 is essential to catalyze the first step of the Fap1 glycosylation (3). However, it is interesting to note that VT343 selected by its adhesion deficiency had the same mutation, indicating the importance of Gtf1 in the Fap1 biogenesis. Failure to fully complement the adhesion defect in spite of complete restoration of mature Fap1 expression may indicate that the overexpression of glycosyltransferase Gtf1 deregulates some Fap1-dependent or -independent adhesion process.
The second mutant group contains six mutants. Five of them, including VT321 (Fig. 2A, lane 3), VT361 (lane 5), VT377 (lane 6), VT379 (lane 7), and VT380 (lane 8), secreted a large amount of mature Fap1 into their culture media. This secreted protein reacted with all three Fap1-specific antibodies (Fig. 2A, lanes 3 and 5 to 8). Notably, these mutants did not retain detectable mature Fap1 in the cell lysates (Fig. 2B, lanes 3 and 5 to 8), suggesting a defect in the CWA domain of Fap1. Another mutant, VT325, did not react with any Fap1-specific antibody (Fig. 2A and B, lane 4), implying a defect in the fap1 structural gene. We transformed the full-length fap1 gene into each mutant and then analyzed the mature Fap1 production in the complemented strains. All six mutants were complemented by the full-length fap1 as determined by enzyme-linked immunosorbent assay (ELISA) analysis (data not shown), demonstrating that they have defects in fap1. Western blot analysis with Fap1-specific antibodies confirmed that fap1-complemented strains expressed mature 200-kDa Fap1 in both culture media (Fig. 2C, lanes 4, 6, 8, 10, 12, and 14) and cell lysates (Fig. 2D, lanes 4, 6, 8, 10, 12, and 14), further supporting the conclusion that these mutants belong to fap1 mutant groups.
![]() View larger version (43K): [in a new window] |
FIG. 2. Characterization of nonadherent fap1 mutants. (A and B) Fap1 expression profiles of culture supernatants (A) and cell lysates (B) of the wild type (WT) (lane 1), fap1 mutant (lane 2), VT321 (lane 3), VT325 (lane 4), VT361 (lane 5), VT377 (lane6), VT379 (lane 7), and VT380 (lane 8), as determined by Western blotting analysis with three Fap1-specific antibodies. Arrows point to the positions corresponding to the Fap1 protein. (C and D) Western blotting analyses of culture media (C) and cell lysates (D) of the wild type (lane 1), fap1 mutant (lane 2), and fap1 chemically mutagenized strains and their complemented counterparts VT321 (lane 3), VT321/fap1+ (lane 4), VT325 (lane 5), VT325/fap1+ (lane 6), VT361 (lane 7), VT361/fap1+ (lane 8), VT377 (lane 9), VT377/fap1+ (lane 10), VT379 (lane 11), VT379/fap1+ (lane 12), VT380 (lane 13), and VT380/fap1+ (lane 14) with Fap1-specific peptide antibodies. (E) Diagrammatic depiction of fap1 alleles from VT321, VT325, and FW213. (F) Adhesion of S. parasanguinis FW213 and its fap1 mutant derivatives. Wild-type strain FW213, the fap1 mutant, and VT321, VT325, VT361, VT377, VT379, and VT380 and their complemented strains were evaluated for their ability to bind to SHA.
|
There was no mutation identified in the CWA domain of Fap1 from the VT361, VT377, VT379, and VT380 mutants, despite the fact that the mutant phenotypes are very similar to that observed for VT321, suggesting that the mutation in these fapl genes is located in the RII region that is adjacent to the CWA domain of Fap1. We attempted to amplify this region but failed to obtain satisfactory PCR products that are amenable to sequencing. This is likely due to the presence of extensive repeated DNA sequences (28). In fact, a defined mutant constructed by inserting an erythromycin resistance cassette at the junction regions between RII and CWA displayed a very similar phenotype (28).
As VT325 failed to produce any Fap1-reactive band, we hypothesize that it might have a mutation at the very beginning of the amino terminus. Sequencing analysis of the 5' fap1 fragment revealed the presence of a mutation in the NRII region of fap1. A C-to-T substitution at codon 224 led to pretermination of Fapl translation (Fig. 2E). The truncated Fap1 does not react with Fap1-peptide specific antibody mAbE42, indicating the E42 epitope is located outside of this region.
The adherence levels of VT321, VT361, VT377, VT379, and VT380 were well restored by the fap1 complementation (Fig. 2F). These data suggest the identified mutations are responsible for the observed adhesion phenotypes, supporting the concept that Fap1 is a major bacterial adhesin.
Interestingly another fap1-related mutant, VT325, behaved differently. The complemented strain could produce mature Fap1 (Fig. 2C and D, lane 6); however, it failed to restore bacterial adhesion, suggesting this strain may have an additional Fap1-independent mutation. To further characterize the strain, we determined the labeling efficiency of each mutant. VT325 and its fap1-complemented derivative had remarkably low efficiency to incorporate [3H]thymidine (data not shown), suggesting a global defect in bacterial DNA metabolism. This may explain why even the complemented VT325 cannot adhere well. The global defects may affect the Fap1-independent bacterial adhesion mechanism as diverse adhesion molecules are present in oral streptococci and can interact with host cells in a concerted or independent manner.
Gap1 is required for complete glycosylation of Fap1. The third mutant group, VT324 (Fig. 3A, lane 3), displayed a distinct Fap1 expression profile which is similar to the phenotype observed in secY2, gap1, gap3, and secA2 mutants (Fig. 3A, lanes 4 to 7). They all expressed a 470-kDa polypeptide that reacted with peptide-specific antibody mAbE42 (Fig. 3A, top panel, lanes 3 to 7) and one glycan-specific antibody, mAbD10 (Fig. 3A, middle panel, lanes 3 to 7), but not with the other glycan-specific antibody, mAbF51 (Fig. 3A, bottom panel, lanes 3 to 7). These data suggest that the Fap1 precursor lacks F51-specific glycan epitope(s) and is not completely glycosylated in VT324.
![]() View larger version (34K): [in a new window] |
FIG. 3. Characterization of a nonadherent gap1 mutant. (A) The Fap1 expression profiles of cell lysates of the wild type (lane 1), fap1 mutant (lane 2), VT324 (lane 3), secY2 mutant (lane 4), gap1 mutant (lane 5), gap3 mutant (lane 6), and secA2 mutant (lane 7) were determined by Western blotting analysis with three Fap1-specific antibodies. (B) Western blotting analyses of the wild type (lane 1), fap1 mutant (lane 2), VT324 (lane 3), and VT324 complemented with the full-length gap1 (lane 4), secY2 (lane 5), gap3 (lane 6), and secA2 (lane 7) genes. (C) Adhesion of S. parasanguinis FW213 and gap1 mutant derivatives to SHA.
|
The C-terminal 13-amino-acid motif is required for Gap1 function. The mutation in the gap1 gene of VT324 was determined to be an A-to-T substitution at codon 513 (Fig. 4A). This mutation led to premature termination of Gap1. Loss of the C-terminal 13 amino acids inhibited mature Fap1 production, suggesting the C terminus is very important for the maintenance of the Gap1 function. The 13 amino acids are conserved in other Gap1 homologs from S. agalactiae, S. gordonii, S. sanguinis, S. pneumoniae, Staphylococcus haemolyticus, or Lactobacillus johnsonii (Fig. 4B).
![]() View larger version (33K): [in a new window] |
FIG. 4. The Gap1 C-terminal motif is important for Gap1 function and Fap1 biogenesis. (A) Diagrammatic depiction of a gap1 allele from VT324. (B) Homology comparison of the C-terminal domain of Gap1 of S. parasanguinis and its homologs from S. agalactiae (AAZ95528), S. gordonii (AAK16998), S. sanguinis (ABN44261), S. pneumoniae (AAK75837), Staphylococcus haemolyticus (BAE03637), and Lactobacillus johnsonii (AAS08375). The conserved amino acid residues are highlighted. (C) A key amino acid residue in the C-terminal motif is important for Gap1 function. Cell lysates prepared from the wild type (lane 1), fap1 mutant (lane 2), and VT324 (lane 3) as well as Gap1 site-directed mutants W518A (lane 4) and W518Y (lane 5) were analyzed by Western blotting with three Fap1-specific antibodies, mAbE42 (I), mAbD10 (II), and mAbF51 (III), or anti-FimA antibody (IV). Arrows point to the positions corresponding to Fap1 or FimA.
|
The C-terminal 13-amino-acid motif is not required for the interaction between Gap1 and Gap3.
Recently we have determined that Gap1 interacts with Gap3 and an N-terminal motif in Gap1 is important for the interaction and also required for biogenesis of Fap1. The involvement of the C-terminal motif in the Fap1 glycosylation suggests that Gap1 has a distinct functional domain. As the C-terminal motif is structurally aligned to a functional glycosylation domain, it may not be involved in the interaction between Gap1 and Gap3. To test this, we constructed and purified recombinant GST, GST-Gap1, and GST-Gap1(
513-525) proteins (Fig. 5A) and performed in vitro GST pull-down assays to determine the effect of the C-terminal deletion on the Gap1-Gap3 interaction. The interaction was not affected by the deletion (Fig. 5B, lanes 2 and 3), suggesting the C-terminal Gap1 is not required for the protein-protein interaction. This result is consistent with the notion that the C terminus has a glycosylation functional domain and represents a distinct functional domain for Gap1.
![]() View larger version (13K): [in a new window] |
FIG. 5. The C-terminal deletion does not affect interaction between Gap1 and Gap3. Gap1( 513-525) and Gap1 interactions with Gap3 were determined by in vitro GST pull-down assays. (A) SDS-polyacrylamide gel electrophoresis analyses of GST (lane 1), GST-Gap1 (lane 2), and GST-Gap1( 513-525) (lane 3) fusion proteins purified using glutathione Sepharose beads from respective bacterial strains. The gel was stained with Coomassie blue. M, protein marker. (B) In vitro GST pull-down assays. The purified GST (lane 1), GST-Gap1 (lane 2), or Gap1( 513-525) (lane 3) glutathione Sepharose beads were incubated with in vitro-translated c-Myc-Gap3. The captured protein complexes were subjected to Western blot analyses with c-Myc antibody. "Input" represents in vitro-translated c-Myc-Gap3.
|
Published ahead of print on 13 October 2008. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»